Why Allergists & Immunologists Get Sued: The Allergy Shot, the Anaphylaxis, and the Epinephrine That Came Late

By John Mahoney · June 2026 · 8 min read

Allergy and immunology is one of the quieter specialties in the courthouse and one of the easiest to misjudge at intake, because its risk profile is unusual. Most of what an allergist does — testing, counseling, prescribing — is low-acuity and rarely litigated. But a small slice of the work is the deliberate, in-office introduction of an allergen into a sensitized patient: the allergy shot, the drug challenge, the food challenge. When those go wrong, they go wrong fast and catastrophically, and the case turns on minutes — how long the patient was observed and how quickly epinephrine reached them. An attorney who treats every allergy intake as a low-value diagnostic file will miss the rare, high-severity anaphylaxis case hiding in the stack. This guide explains where allergy and immunology liability actually lives, the cannot-miss failures behind it, and what separates a strong case from a weak one — for plaintiff and defense med-mal attorneys.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. The patterns below draw on closed-claims summaries, specialty-society guidance, and litigation reporting that span different eras and definitions; treat them as directional, verify against the controlling jurisdiction, and value any individual case on its own record.

The Frequency-and-Severity Reality

By frequency, allergy and immunology sits near the bottom of the malpractice tables. It is consistently grouped among the lowest-risk specialties in physician closed-claims analyses, with an annual claim frequency well below the all-specialty average and a small absolute share of total claims. Most allergists practice for years without a paid claim, and many of the claims that are filed close without payment or resolve for the defense. The day-to-day caseload — skin testing, immunotherapy maintenance, asthma and rhinitis management — generates relatively little litigation by volume.

Severity is a different story, and it is where this specialty hides its teeth. The defining exposure is in-office anaphylaxis — a death or hypoxic-injury event arising from a treatment the physician chose to administer to a patient known to be sensitized. When a healthy, working-age patient comes in for a routine allergy shot and leaves with an anoxic brain injury or does not leave at all, the damages model is severe and the sympathy factor is high, because the harm flowed directly from an elective, physician-administered intervention. A smaller group of high-severity claims arises from missed or delayed diagnosis of serious immunologic disease and from drug-allergy labeling errors that lead to a preventable reaction. The screening lesson is that frequency badly understates this specialty's tail risk: the rare anaphylaxis file can be worth more than dozens of routine ones, and it must be pulled out of the stack immediately.

The Dominant Allegation Types

Allergy and immunology claims cluster around the in-office reaction, the labeling error, and the missed diagnosis, with a consent thread running through the procedural ones:

• Anaphylaxis during in-office immunotherapy and challenge testing — reactions to allergy shots, skin testing, and drug or food challenges, frequently alleging a dosing or vial-mixing error, inadequate post-injection observation, or delayed/absent epinephrine. This is the highest-severity category.
• Failure to prescribe, teach, or refill epinephrine — not equipping an at-risk patient with an auto-injector, failing to provide a written anaphylaxis action plan, or failing to counsel on its use.
• Drug-allergy mislabeling and penicillin delabeling errors — wrongful removal of an allergy label that precedes a serious reaction, or failure to remove an unverified label that blocks first-line therapy.
• Missed or delayed diagnosis of immunologic disease — primary immunodeficiency, hereditary angioedema, mastocytosis, or systemic allergic/immunologic conditions whose delay caused harm.
• Lack of informed consent / failure to communicate risk — central to immunotherapy and challenge-testing claims, where the patient was not warned of the anaphylaxis risk or the observation requirement.

The structural point: by count, this is a small docket, but it is dominated in dollars by the acute in-office event. Any intake should be triaged first on whether it involves a physician-administered allergen reaction, because the merit analysis, the experts, and the damages for that category are entirely different from a routine diagnostic complaint.

The Cannot-Miss Conditions and Failures

The conditions and failures that drive allergy and immunology litigation are:

• Anaphylaxis during allergen immunotherapy ("allergy shots"). The highest-severity exposure. The recurring failures are a dosing or vial-mixing error (wrong concentration, wrong vial, dose advanced too fast after a gap or a prior reaction), inadequate post-injection observation (the patient left or was not watched for the standard observation window), and delayed or absent epinephrine (treated with antihistamines first, or epinephrine not given promptly intramuscularly). A fatal or hypoxic outcome very often traces to the minutes between the reaction and the injection.
• Anaphylaxis during drug, food, or skin challenge testing — the deliberate, supervised reintroduction of an allergen carries the same observation-and-epinephrine duties, and the same failures recur.
• Failure to prescribe and teach the epinephrine auto-injector — a patient with a documented anaphylaxis risk who was sent home without a device, a refill, or an action plan, and who later died or was injured in a community reaction.
• Drug-allergy labeling errors — an erroneous penicillin delabeling followed by a serious beta-lactam reaction, or a failure to evaluate and remove an unverified label that forced inferior, harmful alternative therapy.
• Missed or delayed diagnosis of primary immunodeficiency or serious immunologic disease — recurrent infections, hereditary angioedema, or mastocytosis worked up too late, allowing avoidable harm.

For the acute side, the single most actionable screening question is the timing question: how long was the patient observed, and how fast did epinephrine reach them? An anaphylaxis claim very often turns on the observation-time record and the medication-administration timestamps rather than on the decision to treat at all. For the labeling and diagnostic side, the decisive question is whether the chart documents the basis for the label change or the workup, and whether the harm followed from a defect in that reasoning.

The Contributing Factors That Drive Payouts

Across allergy and immunology claims, the recurring contributing factors are:

• Clinical judgment and dosing — the costliest factor in the acute cases: the wrong concentration or vial, advancing the dose too aggressively after a gap or a prior systemic reaction, and proceeding with a challenge in a patient who should have been deferred.
• Emergency response and time-to-epinephrine — the lever that most often decides outcome. Reaching for antihistamines or steroids first, hesitating on intramuscular epinephrine, or an office that was not equipped and drilled for anaphylaxis converts a survivable reaction into a catastrophic one.
• Observation-time and monitoring protocol — letting the patient leave before the standard post-injection observation window, or not monitoring during it, is a distinctive and decisive allergy-specific failure.
• Communication and informed consent — failure to warn of the anaphylaxis risk, to explain why observation is required, or to equip the patient with an auto-injector and an action plan.
• Documentation — incomplete records of the dose given, the vial and concentration, the consent, the observation time, and the exact medication-administration timestamps, which weaken the defense.

Two of these are allergy-and-immunology-specific levers. The first is the time-to-epinephrine record: in an in-office anaphylaxis death, the line between a defensible file and a paid claim is often whether the chart shows epinephrine was given promptly and intramuscularly rather than after a delay or after second-line agents. The second is the observation-time and emergency-preparedness record — the standard-of-care timing record. Whether the patient was held for the recommended observation window, and whether the office had the equipment, protocol, and trained staff to respond, frequently decides the case. Documentation rarely creates liability here, but the timing record consistently decides whether a claim is paid.

Strong Case vs. Weak Case in Allergy & Immunology Malpractice

The same factors grade the file, and the framing is useful to both sides.

What makes an allergy & immunology case strong (plaintiff) / dangerous (defense)

• A documented dosing or vial-mixing error — wrong concentration, wrong vial, or a dose advanced despite a prior systemic reaction — followed by anaphylaxis, a clean breach-and-causation chain.
• An in-office reaction where the record shows epinephrine was delayed, given after antihistamines, or not given intramuscularly, with a fatal or hypoxic outcome that earlier treatment would likely have prevented.
• A patient who was allowed to leave before the standard post-injection observation window and reacted off-site, with no documented observation time.
• An at-risk patient discharged without an epinephrine auto-injector or action plan, or an erroneous penicillin delabeling that preceded a serious reaction, with thin documentation of the reasoning.

What makes an allergy & immunology case weak (plaintiff) / defensible (defense)

• A correctly dosed, correctly mixed injection with documented consent, a recorded observation period, and prompt intramuscular epinephrine on the first sign of a systemic reaction — the timing record clean.
• An office with a documented anaphylaxis protocol, stocked emergency equipment, trained staff, and timestamps showing a fast, guideline-concordant response, framing the outcome as a known, disclosed risk rather than negligence.
• A patient whose record shows they left against advice before the observation window ended, declined the auto-injector prescription, or did not follow the action plan.
• A label change or diagnostic workup performed to specialty standards with the basis documented, where the harm did not flow from a defect in that reasoning.

Allergy and immunology rewards a fast triage. On the acute side, the case lives or dies on the dosing record, the observation-time documentation, and the time-to-epinephrine chain — the minutes are the merits. On the labeling and diagnostic side, it turns on whether the chart shows a defensible basis for the label change or the workup and whether the harm followed from a defect in it. Whichever side you are on, grading the file means pulling the timing and administration records first and pressure-testing the expert who will carry the standard-of-care timing opinion.

Bottom Line

Allergists and immunologists get sued rarely, and most of the specialty's caseload is low-acuity and low-value. But the docket hides a sharp severity spike: in-office anaphylaxis during allergy shots and challenge testing produces a small number of catastrophic, high-sympathy claims, and drug-allergy labeling errors and missed immunologic diagnoses add to the high-severity tail. The cannot-miss facts are the dosing or vial-mixing error, the inadequate observation window, the epinephrine that came late or not intramuscularly, the auto-injector that was never prescribed, and the penicillin label that was wrongly changed. Whether you are screening these cases for the plaintiff or defending them, do not let the low frequency fool you — pull the rare acute file out of the stack, and grade it on the dosing record, the observation-time documentation, and the time-to-epinephrine timeline, not on the routine nature of the visit alone.

Questions? Contact us at [email protected] or (856) 979-6525

🔎 Screening a case in a different specialty? Browse all 70 specialty malpractice-risk guides in one place — Why Doctors Get Sued: Malpractice Risk by Specialty →